Skeletal Metastasis Evaluation: Value and Impact of PET/Computed Tomography on Diagnosis, Management and Prognosis.
Choline
FDG
Fluciclovine
NaF
PET/CT
Skeletal metastasis
Journal
PET clinics
ISSN: 1879-9809
Titre abrégé: PET Clin
Pays: United States
ID NLM: 101260152
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
entrez:
14
11
2018
pubmed:
14
11
2018
medline:
31
1
2019
Statut:
ppublish
Résumé
A number of PET agents are useful for evaluation of skeletal metastatic disease, and have significant advantages over 99mTc-MDP scintigraphy, including superior diagnostic accuracy, higher spatial resolution, and shorter imaging times- often with the ability to depict soft tissue local recurrence and metastasis in the same examination. While these agents have excellent diagnostic utility, they are not 100% specific for skeletal metastasis, and so normal patterns of biodistribution, benign osseous lesions that may demonstrate radiotracer uptake, and the significance of morphologic changes on CT such as osteolysis or osteosclerosis must be kept in mind to ensure accurate interpretation.
Identifiants
pubmed: 30420213
pii: S1556-8598(18)30095-6
doi: 10.1016/j.cpet.2018.08.006
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
103-120Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.